Soluble Mesothelin May Help Predict Treatment Outcomes

New research reported in a study published in Oncotarget concluded that a protein typically used to track and diagnose mesothelioma may be a helpful tool in predicting treatment outcomes. By tracking soluble mesothelin-related protein (SMRP) levels in the blood doctors can determine the efficacy of the treatments being used.

There are many prognostic tools that doctors use to predict the outcome of treatments such as age, overall health, and at which stage the cancer is caught. Seeking more reliable prognosis tools, the research team analyzed 579 cases. Dr. Long Tian, an author of the study stated that, “The results showed that soluble mesothelin level was significantly correlated with the survival of malignant pleural mesothelioma.”

The tests confirmed that those with the highest level of SMRP in the blood had the worst prognosis. Used in conjunction with other bio-markers SMRP analysis will likely provide the highest degree of accuracy.

The Paul Law Firm advocates for victims of asbestos-related diseases. If you or a loved one is suffering from mesothelioma, call the Paul Law Firm. With over 2.5 billion dollars collected for victims of asbestos exposure, we have the knowledge and the experience to fight for you. We also understand that fighting doesn’t just happen in the courtroom. It also happens in a lab where we are fighting for a cure. Check out the Mesothelioma Research Foundation of America here.

Call us today at 1-855 88 LEGAL (885-3425) or contact us online to discuss your case with one of our experienced mesothelioma lawyers

mesothelioma, mesothelioma treatment, mesothelioma lawyer, mesothelioma diagnosis, mesothelioma research, workers at risk for asbestos exposure, riskiest jobs for asbestos exposure